REVA Medical, Inc.
Founded in 1998, REVA Medical, Inc. is dedicated to developing minimally invasive medical devices that leverage our proprietary technologies.
Guided by an executive management team with extensive product development experience and working closely with skilled interventional cardiologists in multiple countries, our primary focus is the development of drug-eluting bioresorbable coronary scaffolds for the treatment of cardiovascular disease, the leading cause of death worldwide.
REVA Medical, Inc. has developed a proprietary bioresorbable scaffold, as an alternative to metal stents, to treat coronary artery disease. Scaffolds provide restoration of blood flow, support the artery through the healing process, then disappear (or “resorb”) from the body over a period of time. This resorption allows the return of natural movement and function of the artery, a result not attainable with permanent metal stents. The Company’s Fantom® scaffold has been designed to offer an ideal balance of thinness and strength, with distinct ease-of-use features including complete scaffold visibility under x-ray, expansion with one continuous inflation, and no procedural time limitations.